The objective of this long-term study is to evaluate the long term effectiveness and safety
of AUGMENT® Bone Graft vs. autologous bone graft. The study involves evaluation of subjects
originally treated under Protocol BMTI-2006-01.
Subjects will be asked to consent and return to provide long-term follow-up data at or after
60 months (5 years) have elapsed since their original surgery as a subject in protocol
STUDY HYPOTHESIS: The effectiveness and safety profile for AUGMENT® Bone Graft is maintained
and remains comparable to that of autologous bone graft over long-term subject follow-up.
REGULATORY PHASE: Post-approval study